Why unicorn-maker Glen Tullman, CEO of Transcarent, is backing virtual diabetes clinic 9am.health April 17, 2022 Auto Bot 9am.health, Consumer / Employer, diabetes management, Health Tech, News, prediabetes, transcarent, Type 2 Diabetes 0 The company has $20 million in funding, including $16 million from a Series A funding round announced Wednesday, and backing from the veteran health executive who has already been at the helm of two startups-turned-unicorns.